TP53 and neoplasm: While a 10% cutoff has been suggested for breast cancer based on TP53 mutations, recent studies report that overexpression in at least 80% of tumour cells significantly correlates with TP53 mutations, although this arbitrary cutoff requires further validation.15, 16, 41, 42, 43